- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on DIABETES MELLITUS, NONINSULIN-DEPENDENT, 2 (Disorder) in Japan
Total 417 results
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, New Zealand, Spain, Japan, Finland, Germany, Greece, Romania, South Africa, Denmark, Colombia, Poland, United Kingdom, Mexico, Australia, Belgium, Ireland
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Israel, Italy, Russian Federation, Turkey, Japan, Czechia, Spain, United Kingdom, United States, Australia, Hungary, Puerto Rico, Mexico, Austria, Germany, Denmark, Croatia, Greece, Romania, Taiwan, Brazil, Netherlands, Poland, Lithuania and more
-
Novo Nordisk A/SCompletedHeart Failure With Preserved Ejection Fraction (HFpEF) and Diabetes Mellitus, Type 2United States, Spain, Hungary, United Kingdom, India, Netherlands, Germany, Japan, Canada, Czechia, Argentina, Austria, Israel, Italy, Poland, Sweden
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Belgium, Canada, China, France, Germany, Greece, India, Ireland, Japan, Korea, Republic of, Mexico, Philippines, Slovakia, Slovenia, Switzerland, Taiwan, Turkey, Ukraine
-
BayerCompleted
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2United States, Argentina, Austria, Belgium, Canada, China, Croatia, Czech Republic, Finland, Germany, Greece, Hungary, India, Israel, Italy, Japan, Korea, Republic of, Malaysia, Mexico, Netherlands, New Zealand, Philippines, Poland, R... and more
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2Israel, Japan, Mexico, Argentina, Turkey, Australia, Algeria, Saudi Arabia, Brazil, China
-
Novo Nordisk A/SActive, not recruitingDiabetes Mellitus, Type 2United States, Spain, Netherlands, United Kingdom, Canada, India, Austria, Korea, Republic of, Germany, Brazil, Malaysia, Thailand, Japan, Argentina, Serbia, Turkey, China, Russian Federation, Taiwan, Hong Kong, Mexico, Romania, Ukr... and more
-
Sanwa Kagaku Kenkyusho Co., Ltd.CompletedType 1 Diabetes MellitusJapan
-
AstraZenecaCompletedChronic Kidney Diseases | Type 2 Diabetes MellitusSpain, United Kingdom, New Zealand, Australia, Canada, Poland, Germany, Japan
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Colombia, Croatia, Czech Republic, Denmark, Estonia, France, Georgia, Greece, Hong Kong, Hungary, India, Indonesia, Israel, Italy, Japan, Korea, Republic of, Malaysia and more
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Spain, Taiwan, United Kingdom, Czechia, Bulgaria, Israel, Canada, Germany, Malaysia, Argentina, Hungary, Russian Federation, Poland, Ukraine, Korea, Republic of, Croatia, Japan, Netherlands, Portugal, South Africa, ... and more
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Taiwan, Philippines, Australia, Hong Kong, Korea, Republic of, Canada, Italy, Malaysia, United Kingdom, Mexico, Greece, Spain, Netherlands, Switzerland, Israel, Portugal, Germany, Finland, Norway, Romania, Sweden, Serbia and more
-
Osaka Saiseikai Nakatsu HospitalCompletedDiabetes MellitusJapan
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Australia, Canada, Finland, Israel, Japan, New Zealand, Slovakia, Sweden
-
BayerCompletedChronic Kidney DiseaseBelgium, Finland, France, China, Hong Kong, Switzerland, United States, Turkey, Greece, New Zealand, Poland, South Africa, Spain, Korea, Republic of, Portugal, Taiwan, Japan, Russian Federation, Singapore, Australia, Netherlands, ... and more
-
Eli Lilly and CompanyCompletedDiabetes MellitusJapan
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 1Japan
-
Hiroshima UniversityKAWAMOTO FOODS CO., LTD.Completed
-
Astellas Pharma IncCompletedType 1 Diabetes MellitusJapan
-
Hiroshima UniversityNewBio Enterprise Co., ltd.Completed
-
Ministry of Health, Labour and Welfare, JapanBayer; Japan Heart FoundationUnknownHypertension | Diabetes Mellitus | HyperlipidemiaJapan
-
Boehringer IngelheimRecruitingObesity | Diabetes Mellitus, Type 2United States, Korea, Republic of, Belgium, Spain, China, Australia, Hungary, Canada, Czechia, Poland, New Zealand, Denmark, Finland, Germany, Greece, Netherlands, Sweden, Japan, United Kingdom
-
Hiroshima UniversityAgricultural Producers' Cooperative Corporation Shinpo-enCompleted
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Argentina, Brazil, Canada, China, Germany, India, Israel, Italy, Japan, Korea, Republic of, Mexico, Puerto Rico, Russian Federation, Saudi Arabia, Spain, Turkey, United Arab Emirates, United Kingdom
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1Japan
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Germany, Spain, United States, Canada, Taiwan, Korea, Republic of, Finland, Denmark, France, Japan, Philippines, Vietnam
-
BayerRecruitingType 2 Diabetes Mellitus | Chronic Kidney DiseaseUnited States, Belgium, Spain, Taiwan, Korea, Republic of, Japan, Italy, Denmark, Israel, Canada, France, India, Netherlands, Germany
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Japan
-
Eli Lilly and CompanyAlkermes, Inc.Completed
-
Tokyo UniversityCompletedDiabetes Mellitus | Glucose IntoleranceJapan
-
SanofiCompleted
-
TakedaCompleted
-
Sapporo Health Promotion FoundationCompletedHypertension | Diabetes Mellitus | HyperlipidemiaJapan
-
Novo Nordisk A/SActive, not recruitingDiabetes Mellitus, Type 2 | Peripheral Arterial DiseaseSpain, Taiwan, China, India, United States, Canada, Thailand, Austria, Malaysia, Germany, Poland, Japan, Czechia, Greece, Belgium, Denmark, Hungary, Latvia, Norway, Sweden
-
AstraZenecaCompletedDiabetes Mellitus, Type 2United States, Austria, Belgium, Canada, Denmark, France, Germany, Italy, Netherlands, Spain, United Kingdom, Czechia, Hungary, Thailand, Turkey, Vietnam, Korea, Republic of, Brazil, Peru, Philippines, Poland, China, Japan, Taiwan, Hong... and more
-
AbbVie (prior sponsor, Abbott)CompletedDiabetic Nephropathy | Chronic Kidney DiseaseJapan
-
AstraZenecaCompletedType 1 Diabetes MellitusJapan
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 1United States, India, Italy, Russian Federation, United Kingdom, Canada, Netherlands, Austria, Japan, Spain, Germany, Turkey
-
Novo Nordisk A/SRecruitingObesity | Type 2 Diabetes | Chronic Kidney DiseaseUnited States, Spain, Poland, Thailand, India, France, Argentina, Canada, Japan, Greece, Slovakia, Hungary, Brazil
-
BayerCompletedType 2 Diabetes Mellitus | Chronic Kidney DiseaseSpain, Belgium, United States, Russian Federation, Hong Kong, Singapore, Taiwan, Korea, Republic of, Canada, Austria, Italy, Japan, Denmark, Australia, Bulgaria, Czechia, Finland, Israel, Netherlands, Sweden, Portugal
-
Nagoya UniversityUnknownHypertension | Healthy | Diabetes Mellitus | Hyperlipidemia | Metabolic Syndrome XJapan
-
Shiga UniversityUnknownHypertension | Diabetes Mellitus | AlbuminuriaJapan
-
National Cerebral and Cardiovascular CenterJapan Heart FoundationTerminatedMyocardial Infarction | Diabetes MellitusJapan
-
Eli Lilly and CompanyCompletedType 1 Diabetes MellitusUnited States, Czechia, France, Spain, Japan, Germany, Italy, Brazil, Denmark, Austria, United Kingdom, China, Russian Federation, Mexico, Poland, Ukraine, Israel, Puerto Rico
-
Eli Lilly and CompanyCompletedType 1 Diabetes MellitusItaly, Japan, United States, Puerto Rico, Spain, Taiwan, Mexico, Austria, Germany, Poland, New Zealand, Romania, Russian Federation, Argentina, India, Sweden, Slovakia, Australia, Brazil, Greece
-
TakedaCompleted
-
SanofiCompletedType 1 Diabetes MellitusJapan, Spain, Germany, United States, France, Hungary, Poland, Russian Federation
-
SanofiCompletedType 1 Diabetes MellitusFrance, Czechia, Chile, Israel, Spain, Hungary, Mexico, Serbia, Japan, Canada, Brazil, Sweden, Denmark, Argentina, United States, Bulgaria, Germany, Italy, Latvia, North Macedonia, Poland, Romania, Russian Federation, United Kingdom